ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0847

A Psychometric Analysis of the Self-Efficacy for Managing Chronic Disease Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study

Alyssa Choi1, Chelsea Rapoport2, Linda Kwakkenbos3, Marie-Eve Carrier4, Karen Gottesman5, Scott Roesch6, Brett Thombs7 and Vanessa Malcarne6, 1SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, La Jolla, CA, 3Department of Clinical Psychology, Radboud University Behavioural Science Institute, Nijmegen, Netherlands, 4Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada, 5Scleroderma Foundation, Southern California Chapter, Danvers, MA, 6SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology; Department of Psychology, San Diego State University, San Diego, CA, 7Lady Davis Institute for Medical Research, Jewish General Hospital; Department of Psychiatry, McGill University, Montréal, QC, Canada

Meeting: ACR Convergence 2021

Keywords: Measurement, psychosocial factors, Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Session Title: Research Methodology Poster (0846–0854)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Self-efficacy is a key determinant of health behaviors and the target mechanism of self-management programs for patients with chronic diseases. The Self-Efficacy for Managing Chronic Disease (SEMCD) scale, a brief self-report instrument, has been widely used to measure self-efficacy in chronic disease populations and is validated in English for use in people with systemic sclerosis (SSc). However, it is essential that translations of measures be examined for psychometric equivalence across populations, and no research has yet ascertained that SEMCD scores are comparable across languages. The present study examined the cross-language measurement equivalence of the SEMCD in a sample of English- or French-speaking adults with SSc.

Methods: Adults with SSc (N = 2159; 87.4% female; 57.3% limited SSc; 68.3% English-speaking) from 46 centers were enrolled in the Scleroderma Patient-Centered Intervention Network (SPIN) Cohort. All participants were classified as having SSc according to the 2013 ACR/EULAR classification criteria. The SEMCD scale includes 6 items and higher scores indicate higher levels of self-efficacy. Confirmatory factor analysis (CFA) was used to confirm the single-factor structure of the SEMCD scale. Cronbach’s coefficient alpha and McDonald’s omega were used to evaluate internal consistency reliability. Multiple group confirmatory factor analysis (MGCFA) was used to determine whether the single-factor structure was supported in both languages. The Multiple-Indicator Multiple-Cause (MIMIC) model was used to examine differential item functioning (DIF).

Results: The mean total score on the SEMCD was 6.45 (SD = 2.26, range = 1-10). The SEMCD demonstrated good internal consistency reliability (α = .93, ω = .93). CFA indicated that a one-factor model fit well based on 2 of the 3 tested indices of model fit (Comparative Fit Index [CFI] = .96, Standardized Root Mean Residual [SRMR] = .03). The Root Mean Square Error of Approximation (RMSEA) indicated less than acceptable model fit (RMSEA = .14). Standardized factor loadings for all items were large and statistically significant (all ps < .001; range .755 to .879). Results from the MGCFA supported the metric invariance model as the best fit for the data (Δχ2 [10, N = 2159] = 13.32, p = .206), suggesting that the factor loadings are invariant across English and French language versions. The overall MIMIC model fit well and indicated that the SEMCD items demonstrate cross-language metric equivalence (CFI = .96, SRMR = .03, RMSEA = .12), although a statistically significant but small-magnitude DIF was found for one SEMCD item across language (β = .03, p < .05).

Conclusion: Findings support the use of the SEMCD as a reliable and valid single-factor measure of self-efficacy in SSc. SEMCD scores from English- and French-speaking individuals with SSc can be compared or combined for analysis. Future studies should examine the metric equivalence of the SEMCD across other linguistic and sociodemographic groups (e.g., race/ethnicity, sex).


Disclosures: A. Choi, None; C. Rapoport, None; L. Kwakkenbos, None; M. Carrier, None; K. Gottesman, None; S. Roesch, None; B. Thombs, None; V. Malcarne, None.

To cite this abstract in AMA style:

Choi A, Rapoport C, Kwakkenbos L, Carrier M, Gottesman K, Roesch S, Thombs B, Malcarne V. A Psychometric Analysis of the Self-Efficacy for Managing Chronic Disease Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-psychometric-analysis-of-the-self-efficacy-for-managing-chronic-disease-scale-in-systemic-sclerosis-a-scleroderma-patient-centered-intervention-network-cohort-study/. Accessed January 30, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-psychometric-analysis-of-the-self-efficacy-for-managing-chronic-disease-scale-in-systemic-sclerosis-a-scleroderma-patient-centered-intervention-network-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences